Identifying effective subtype-specific treatment responses in hepatocellular carcinoma in genetically engineered mouse models

被引：0
|
作者：
Mueller, Miryam [1 ]
May, Stephanie [1 ]
Mcgarry, Lynn [2 ]
Kendall, Tim [3 ]
Clark, William [1 ]
Neilson, Matthew [1 ]
Shaw, Robin [1 ]
Jamieson, Thomas [1 ]
Nixon, Colin [1 ]
Blyth, Karen [1 ,2 ]
Murphy, Daniel [1 ,2 ]
Miller, Crispin [1 ,2 ]
Leo, Carlin [1 ,2 ]
Sansom, Owen [1 ,2 ]
Bird, Thomas G. [1 ,2 ,3 ]
机构：
[1] CRUK Beatson Inst, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland
[3] Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-2787
引用
收藏
页码：S508 / S508
页数：1
相关论文
共 38 条
  • [11] Subtype-specific functions of alpha2-adrenergic receptors - insights from transgenic mouse models
    Hein, L.
    Muthig, V
    Knaus, A.
    Brede, M.
    Beetz, N.
    Gilsbach, R.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 17 - 17
  • [12] Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
    Valdez, Kelli Elizabeth
    Fan, Fang
    Smith, William
    Allred, D. Craig
    Medina, Daniel
    Behbod, Fariba
    JOURNAL OF PATHOLOGY, 2011, 225 (04): : 565 - 573
  • [13] Possible pitfalls investigating cell death responses in genetically engineered mouse models and derived cell lines
    Manzl, Claudia
    Baumgartner, Florian
    Peintner, Lukas
    Schuler, Fabian
    Villunger, Andreas
    METHODS, 2013, 61 (02) : 130 - 137
  • [14] TREATMENT OF BRAINSTEM GLIOMAS WITH A CDK 4/6 INHIBITOR USING GENETICALLY ENGINEERED MOUSE MODELS
    Barton, Kelly
    Misuraca, Katherine
    NEURO-ONCOLOGY, 2012, 14 : 30 - 30
  • [15] Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy
    Saito, Ryoichi
    Smith, Christof C.
    Utsumi, Takanobu
    Bixby, Lisa M.
    Kardos, Jordan
    Wobker, Sara E.
    Stewart, Kyle G.
    Chai, Shengjie
    Manocha, Ujjawal
    Byrd, Kevin M.
    Damrauer, Jeffrey S.
    Williams, Scott E.
    Vincent, Benjamin G.
    Kim, William Y.
    CANCER RESEARCH, 2018, 78 (14) : 3954 - 3968
  • [16] Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects
    Miller, Ian S.
    Khan, Sonja
    Shiels, Liam P.
    Das, Sudipto
    O' Farrell, Alice C.
    Connor, Kate
    Lafferty, Adam
    Moran, Bruce
    Isella, Claudio
    Loadman, Paul
    Conroy, Emer
    Cohrs, Susan
    Schibli, Roger
    Kerbel, Robert S.
    Gallagher, William M.
    Marangoni, Elisabetta
    Bennett, Kathleen
    O' Connor, Darran P.
    Dwyer, Roisin M.
    Byrne, Annette T.
    CANCER MEDICINE, 2022, 11 (20): : 3820 - 3836
  • [17] Re: Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2020, 203 (06): : 1061 - 1061
  • [18] Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome
    Wang, Hao
    Song, Shuichuan
    Kou, Geng
    Li, Bohua
    Zhang, Dapeng
    Hou, Sheng
    Qian, Weizhu
    Dai, Jianxin
    Tian, Liang
    Zhao, Jian
    Guo, Yajun
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (11) : 1775 - 1783
  • [19] Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome
    Hao Wang
    Shuichuan Song
    Geng Kou
    Bohua Li
    Dapeng Zhang
    Sheng Hou
    Weizhu Qian
    Jianxin Dai
    Liang Tian
    Jian Zhao
    Yajun Guo
    Cancer Immunology, Immunotherapy, 2007, 56 : 1775 - 1783
  • [20] Development of a novel, highly effective trifold immunotherapeutic approach using autologous humanized PDX models and genetically-engineered mouse models of cancer
    Borchmann, S.
    Ludwig, H.
    Meder, L.
    Lohneis, P.
    Breid, S.
    Reinhardt, C.
    Ullrich, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 247 - 247
1234